Bayban’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.26K Hold
20
– – ﹤0.01% 455
2026
Q2
$3.74K Hold
20
– – ﹤0.01% 490
2026
Q1
$3.87K Hold
20
– – ﹤0.01% 500
2025
Q4
$3.68K Buy
+20
New +$3.51K ﹤0.01% 484

Other funds holding AZN

Bayban's AZN Position: Q3 2026 in Review

Bayban held its AstraZeneca (AZN) position steady in Q3 2026 at 20 shares worth $3.26K. The position accounts for ﹤0.01% of the portfolio, ranked #455.

Bayban first reported a position in AZN in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.87K in Q1 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Bayban held 20 shares of AstraZeneca worth $3.26K as of Q3 2026.
  • Bayban left its AstraZeneca share count unchanged in Q3 2026.
  • AstraZeneca made up ﹤0.01% of Bayban's portfolio in Q3 2026, its #455 holding.
  • Bayban first reported a position in AstraZeneca in Q4 2025 and has held it in 4 quarters since.
  • Bayban's AstraZeneca position peaked at $3.87K in Q1 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Bayban's 13F filing for Q3 2026, filed 5 Nov 2026.